ATE248165T1 - Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten - Google Patents

Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten

Info

Publication number
ATE248165T1
ATE248165T1 AT00940418T AT00940418T ATE248165T1 AT E248165 T1 ATE248165 T1 AT E248165T1 AT 00940418 T AT00940418 T AT 00940418T AT 00940418 T AT00940418 T AT 00940418T AT E248165 T1 ATE248165 T1 AT E248165T1
Authority
AT
Austria
Prior art keywords
cyclodextrin
paroxetine
complexes
derivatives
oral
Prior art date
Application number
AT00940418T
Other languages
English (en)
Inventor
Paolo Mascagni
Giuseppe Bottoni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI001459A external-priority patent/ITMI991459A1/it
Priority claimed from IT1999MI002406 external-priority patent/IT1314232B1/it
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Application granted granted Critical
Publication of ATE248165T1 publication Critical patent/ATE248165T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT00940418T 1999-07-01 2000-06-30 Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten ATE248165T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI001459A ITMI991459A1 (it) 1999-07-01 1999-07-01 Complessi di sali di paroxetina con ciclodestrine
IT1999MI002406 IT1314232B1 (it) 1999-11-17 1999-11-17 Complessi di paroxetina base con ciclodestrine o derivati delleciclodestrine.
PCT/EP2000/006121 WO2001002393A1 (en) 1999-07-01 2000-06-30 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives

Publications (1)

Publication Number Publication Date
ATE248165T1 true ATE248165T1 (de) 2003-09-15

Family

ID=26331667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00940418T ATE248165T1 (de) 1999-07-01 2000-06-30 Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten

Country Status (13)

Country Link
US (1) US6984632B1 (de)
EP (1) EP1109806B8 (de)
JP (1) JP2003503493A (de)
KR (1) KR100759159B1 (de)
AT (1) ATE248165T1 (de)
AU (1) AU5535900A (de)
BR (1) BR0006838A (de)
CA (1) CA2341984A1 (de)
DE (1) DE60004768T2 (de)
DK (1) DK1109806T3 (de)
ES (1) ES2206254T3 (de)
PT (1) PT1109806E (de)
WO (1) WO2001002393A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US7658913B2 (en) 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
EP2120969A4 (de) * 2007-01-23 2010-06-02 Pharmagra Labs Inc Stabilisiertes sulforaphan
JP7390830B2 (ja) * 2019-09-11 2023-12-04 日本食品化工株式会社 医薬活性化合物の苦味抑制剤及び苦味抑制方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (de) 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
CA2206592A1 (en) 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5672612A (en) 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
AU4717997A (en) * 1996-10-28 1998-05-22 Farmarc Nederland Bv Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
JPH10167958A (ja) * 1996-12-09 1998-06-23 Sankyo Co Ltd ロキソプロフェンナトリウム類を含有する口腔内速溶性製剤及びその製造方法
JPH10194996A (ja) * 1996-12-25 1998-07-28 Janssen Pharmaceut Nv アシル化シクロデキストリン含有製薬組成物
JP2001508460A (ja) 1997-01-15 2001-06-26 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー パロキセチン組成物
ATE222103T1 (de) * 1997-02-27 2002-08-15 Novo Nordisk As Inklusionskomplexe in waessriger loesung
HUP9700632A3 (en) * 1997-03-24 1999-10-28 Cyclolab Ciklodextrin Kutato F Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
EE03970B1 (et) * 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
GB9724544D0 (en) 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
EP1102764A1 (de) * 1998-08-08 2001-05-30 Smithkline Beecham Plc Salze von paroxetin

Also Published As

Publication number Publication date
AU5535900A (en) 2001-01-22
ES2206254T3 (es) 2004-05-16
KR100759159B1 (ko) 2007-09-14
JP2003503493A (ja) 2003-01-28
DE60004768D1 (de) 2003-10-02
BR0006838A (pt) 2001-08-07
CA2341984A1 (en) 2001-01-11
DK1109806T3 (da) 2003-12-22
WO2001002393A1 (en) 2001-01-11
KR20010072880A (ko) 2001-07-31
EP1109806B1 (de) 2003-08-27
PT1109806E (pt) 2004-02-27
EP1109806B8 (de) 2003-10-29
US6984632B1 (en) 2006-01-10
EP1109806A1 (de) 2001-06-27
DE60004768T2 (de) 2004-07-08

Similar Documents

Publication Publication Date Title
TR200402656T4 (tr) Antikanser ajanları olarak faydalı tiyofen türevleri
KR880006229A (ko) 항궤양 활성을 갖는 피리딘 유도체
IT1301994B1 (it) Derivati dell'acido ialuronico.
DE69623449D1 (de) Thyroxine/zyklodextrinkomplexe und ihre pharmazeutische formulierung
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
DE60045528D1 (de) Pharmazeutische zusammensetzungen, die ccr5-antagonisierende piperazinderivate enthalten
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
TR199903191T2 (xx) Vorikonazol i�eren ila� form�lasyonlar�.
BG102894A (en) Aryl-heterocyclic salts-including complexes
NZ324887A (en) Piperazine and piperidine compounds with analgesic effect
DK1157037T3 (da) GCSF-konjugater
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
DE60212819D1 (de) Salzformarme polyallylamine
GEP20043250B (en) Use of Indolyl-3-Glyoxylic Acid Derivatives as Anti-tumor Means and Pharmaceutical Compositions Containing the Same
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
EE200100104A (et) 5-HT4 agonisti või antagonisti uus peroraalne ravimvorm
PT992509E (pt) Novos derivados macrolidos
EA200300406A1 (ru) Фармацевтическая композиция дронедарона для парентерального введения
DE60004768D1 (de) Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
ATE284878T1 (de) Pharmazeutische verbindungen mit serotonin rezeptor aktivität
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
DZ1576A1 (fr) Compostions therapeutiques à base de dérives de 1,2-dithiole-3-thione.
PT1058544E (pt) Inibicao da actividade do tnf

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties